newsfilter
← Latest News
GlobeNewswire·

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update

— First patient in platinum-resistant high-grade serous ovarian cancer cohort was dosed on optimized dose and schedule with istisociclib (KB-0742); expect data update in 1H 2025 — — KB-9558 IND-enabling studies for